Addressing complex public health issues requires the combined efforts of government agencies, academic institutions, private-sector companies, and nonprofit organizations. Such partnerships help leverage resources, improve efficiency and cost-effectiveness, and increase the feasibility and scientific impact of the research. NIAID has a successful collaborative track record and continues to promote partnerships with domestic and international entities to advance research on infectious and immunologic diseases; to develop and test new methods of prevention, diagnosis, and treatment; and to accelerate the translation of research findings into medical products.
NIAID brings to each partnership a clearly articulated research mission; access to outstanding scientific expertise and resources, such as specimen repositories; competitive funding opportunities for research and research training; and opportunities to collaborate with scientists in NIAID laboratories.
NIAID partners typically contribute funds, expertise, and/or other resources that complement NIAID research efforts. Partners also may engage in project planning and implementation; contribute staff and research capacity; facilitate access to patient volunteers and other study populations; provide administrative, logistical, and clinical resources; and particularly in foreign countries, serve as liaisons to regional, national, and local government agencies and other organizations.
Last Updated March 23, 2011
Last Reviewed October 18, 2010